Display of QR Code and PvPI Toll-Free number in Pharmacy or Chemist Shops across the country to facilitate ADR reporting by consumers
Tender Notice: For Purchase of Sophisticated laboratory Instrument and Equipment
Tender Notice: For Purchase of Sophisticated laboratory Instrument and Equipment Read More »
Circular dated 18062025 regarding unapproved FDCs
Circular dated 18062025 regarding unapproved FDCs (CIRCULARS) Read More »
DCGI circular regarding Manufacturing and marketing of unapproved FDCs
DCGI circular regarding Manufacturing and marketing of unapproved FDCs (CIRCULARS) Read More »
Regulatory requirements for outsourcing sterilization activity of medical devices by a manufacturer under Medical Device Rules, 2017
Appointment of Registering Authority
Appointment of Registering Authority (NOTIFICATIONS) Read More »
DCGI directs drugs manufacturers to file safety & efficacy data on non-approved FDC formulation before 31st August 2013
Immediate withdrawal of the permission to manufacture all combinations of Tapentadol and all combinations of Caresoprodol
Gastro Resistant Tablets or Capsules, Delayed Release Tablets or Capsules as New Drugs as per Rule 2, (1)(w) of the New Drugs and Clinical Trials Rules, 2019
Evaluation of certain pre 1988 permitted Fixed Dose Combinations (FDCs) de novo for manufacture for sale in the country wiithout due approval from Central Licensing Authority
